Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

PLoS Med. 2019 Jul 5;16(7):e1002842. doi: 10.1371/journal.pmed.1002842. eCollection 2019 Jul.
No abstract available

Publication types

  • Review

MeSH terms

  • Animals
  • Antitubercular Agents / adverse effects
  • Antitubercular Agents / pharmacokinetics
  • Antitubercular Agents / therapeutic use*
  • Drug Development*
  • Humans
  • Microbial Sensitivity Tests
  • Microbiology*
  • Mycobacterium tuberculosis / drug effects*
  • Mycobacterium tuberculosis / pathogenicity
  • Pharmacology, Clinical*
  • Translational Research, Biomedical*
  • Tuberculosis / diagnosis
  • Tuberculosis / drug therapy*
  • Tuberculosis / microbiology
  • Workflow

Substances

  • Antitubercular Agents

Grants and funding

The authors received no specific funding for this work.